Trial Profile
Neuropsychobiological Correlates of Sex-steroid Hormone Manipulation in Healthy Women: a Risk Model for Depression
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Goserelin (Primary)
- Indications Breast cancer; Endometriosis; Salivary gland cancer; Uterine haemorrhage
- Focus Therapeutic Use
- 15 Sep 2020 Results evaluating if the depressogenic effect of GnRHa-intervention also was linked to changes in hippocampal volume presented at the 33rd Annual Congress of the European College of Neuropsychopharmacology
- 12 Dec 2018 New trial record